BackRecursion Pharmaceuticals Overview

Recursion Pharmaceuticals Inventory

Recursion Pharmaceuticals's inventory is $0.

Get informed when a big investor buys or sells

+ Follow
Inventory
$0.00

Peer average / median

Loading

Recursion Pharmaceuticals Inventory History

Loading

Recursion Pharmaceuticals vs. peers: Inventory Comparison

Loading

Recursion Pharmaceuticals Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Recursion Pharmaceuticals (RXRX) FAQ

As of the most recent data (June 2026), RXRX shows a inventory of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, RXRX's inventory is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Recursion Pharmaceuticals is outperforming or lagging.

Tracking RXRX's inventory over time shows whether Recursion Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this inventory page, Stockcircle has Recursion Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect inventory (currently $0) with ownership activity and broader fundamentals.

Recursion Pharmaceuticals's inventory is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.